Shiksha Nation
Skip to content

Apadamtase alfa

Medication

  • 2 min read
  • 3 chapters

Explore on Lably

ToursExplore Lably’s 3D tours

The most common side effects include headache, diarrhea, migraine, abdominal pain, nausea, upper respiratory tract infection, dizziness and vomiting. During the clinical studies, no adverse events, including allergic reactions, were observed during the administration of Adzynma.

Apadamtase alfa was approved for medical use in the United States in November 2023, and in the European Union in August 2024.

Medical uses

Apadamtase alfa is indicated for prophylactic (preventive) or on demand enzyme replacement therapy in people with congenital thrombotic thrombocytopenic purpura.

Sign up free to read the rest

2 more chapters are free with a Lably account.

Already have an account?

More in Health